FrancophonIA/ELRC3.0 huggingface dataset:
English: Remove the plastic flip-top cap from the Respreeza vial.
Danish: Fjern flip-off-hætten af plast fra hætteglasset med Respreeza.
English: Discard the water for injections vial with the entire Mix2Vial set.
Danish: Kasser hætteglasset med vand til injektionsvæsker med hele Mix2Vialsættet.
English: Depending on the nature and severity of the reaction, your doctor may decide whether to slow or stop the infusion completely and start the appropriate treatment.
Danish: Afhængigt af reaktionens beskaffenhed og alvorlighedsgrad kan din læge bestemme, om infusionsvæsken skal indgives langsommere, eller om infusionen helt skal standses.
English: The reconstituted solution should be infused intravenously using a separate dedicated infusion line at an infusion rate of about 0.08 ml / kg bw/ min.
Danish: Efter rekonstitution skal infusionsvæsken infunderes intravenøst vha. en separat dertil bestemt infusionsslange med en infusionshastighed på omkring 0,08 ml/kg kropsvægt/min.
English: The reconstituted solution must be administered using an intravenous administration set (not supplied).
Danish: Infusionsvæsken skal administreres vha. et intravenøst administrationssæt (ikke vedlagt).
English: Epithelial lining fluid measurements (ELF) of alpha1-proteinase inhibitor levels showed a consistent increase following treatment.
Danish: Måling af alfa-1-proteinasehæmmerniveauet i bronkievæske (epithelial lining fluid - ELF) viste en konsistent stigning i forbindelse med behandling.
English: Take the Mix2Vial set together with the blister package and vertically pierce the water for injections vial with the blue tip of the Mix2Vial set (Figure 2).
Danish: Tag Mix2Vial-sættet sammen med blisterpakningen, og stik den blå spids på Mix2Vial-sættet lodret ned i hætteglasset med vand til injektionsvæsker (Figur 2).
English: • 1°solvent vial of 76 ml water for injections
Danish: • 1 hætteglas med 76 ml vand til injektionsvæsker
English: Since human alpha1-proteinase inhibitor is an endogenous human protein, no adverse effects on fertility are expected when given at recommended doses.
Danish: Da human alfa-1-proteinasehæmmer er et endogent humant protein, forventes der ingen negative virkninger på fertilitet, når det gives i de anbefalede doser.
English: Excipients with known effect Respreeza contains approximately 1.9 mg sodium per ml of reconstituted solution (81 mmol/l).
Danish: Hjælpestof(fer), som behandleren skal være opmærksom på Respreeza indeholder ca. 1,9 mg natrium pr. ml infusionsvæske (81 mmol/l).
English: • 1°solvent vial of 95 ml water for injections
Danish: • 1 hætteglas med 95 ml vand til injektionsvæsker
English: Chest pain, chills, pyrexia
Danish: Brystsmerter, kulderystelser, pyreksi
English: Wipe the rubber stopper of the water for injections vial with antiseptic solution and allow it to dry.
Danish: Rengør gummiproppen på hætteglasset med vand til injektionsvæsker med en antiseptisk opløsning, og lad den tørre.
English: Since alpha1-proteinase inhibitor is a normal component of human blood, recommended dose of this medicine is not expected to cause harm to the developing foetus.
Danish: Da alfa-1-proteinasehæmmer er en normal bestanddel i blodet hos mennesker, forventes den anbefalede dosis af dette lægemiddel ikke at forårsage skade på fosteret.
English: The solution should be clear, colourless to slightly yellow, and free from visible particles.
Danish: Opløsningen skal være klar, farveløs til svagt gul og uden synlige partikler.
English: The recommended infusion rate given under section 4.2 should be adhered.
Danish: 4.2 skal overholdes.
English: You may be allergic to human alpha1-proteinase inhibitor even if you have previously received human alpha1-proteinase inhibitors and had tolerated them well.
Danish: Du kan være allergisk over for human alfa-1-proteinasehæmmer, selvom du tidligere har fået human alfa-1-proteinasehæmmer og godt kunnet tåle det. I visse tilfælde kan der opstå alvorlige allergiske reaktioner.
English: Altered sense of touch like burning, tingling or feeling of numbness in your hands, arms, legs, or feet (paraesthesia), flushing, hives (urticaria), scaly rash and rash all over the body, physical weakness (asthenia), infusion-site reactions (such as burning, stinging, pain, swelling or redness at the infusion site (hematoma)).
Danish: Ikke almindelig (kan forekomme hos op til 1 ud af 100 mennesker) Ændret følesans som svie, snurren eller følelsesløshed i hænder, arme, ben eller fødder (paræstesi), blussen, allergiknopper (nældefeber), skællet udslæt eller udslæt over hele kroppen, fysisk svaghed (asteni), reaktioner på infusionsstedet (såsom svie, stikken, smerte, hævelse eller rødme på infusionsstedet (hæmatom)).
English: Place the Respreeza vial on an even and firm surface.
Danish: Anbring hætteglasset med Respreeza på en plan og fast flade.
English: Invert the water for injections vial with the Mix2Vial set attached and vertically pierce the Respreeza vial with the clear tip of the Mix2Vial set (Figure 4).
Danish: Vend hætteglasset med vand til injektionsvæsker med Mix2Vial-sættet monteret, og stik den transparente spids på Mix2Vial-sættet lodret ned i hætteglasset med Respreeza (Figur 4).
English: The recommended dose is 60 mg per kg of body weight and should be administered once per week.
Danish: kg kropsvægt og skal gives en gang om ugen.
English: • how to identify side effects, including signs of allergic reactions, and measures to be taken in case such effects occur (see also section 2 and section 4) Your doctor or your healthcare professional will regularly review your / your caregiver's infusion technique to ensure continued appropriate handling.
Danish: •hvordan du identificerer bivirkninger, herunder tegn på allergiske reaktioner,og hvilke foranstaltninger der skal træffes, hvis sådanne bivirkninger optræder (se også punkt 2 og punkt
English: Wipe the rubber stopper of the Respreeza vial with antiseptic solution and allow it to dry.
Danish: Rengør gummiproppen på hætteglasset med Respreeza med en antiseptisk opløsning og lad den tørre.
English: CSL Behring GmbH Emil-von-Behring-Strasse 76 35041 Marburg Germany
Danish: CSL Behring GmbH Emil-von-Behring-Strasse 76 35041 Marburg Tyskland
English: Open the Mix2Vial set by peeling off the lid (Figure 1).
Danish: ®-overføringssættet ved at trække forseglingen af (Figur 1).
English: • 1°single-use powder vial
Danish: • 1 hætteglas med pulver til engangsbrug
English: Human alpha1-proteinase inhibitor
Danish: Human alfa1-proteinasehæmmer
English: • 1°solvent vial of 20 ml water for injections
Danish: • 1 hætteglas med 20 ml vand til injektionsvæsker
English: One pack contains:
Danish: Respreeza indeholder:
English: Eye disorders
Danish: Hævelse af øjne
English: However, despite these measures, when medicines prepared from human blood or plasma are administered, the possibility of passing on infection cannot be totally excluded.
Danish: På trods af disse forholdsregler kan risikoen for at overføre en infektion imidlertid ikke udelukkes fuldt ud, når der anvendes medicin, som er fremstillet ud fra blod eller plasma fra mennesker.
English: The recommended dose of 60 mg per kg of body weight will take approximately 15 minutes to infuse.
Danish: Det vil tage ca. 15 minutter at infundere den anbefalede dosis på 60 mg pr. kg kropsvægt.
English: Despite this, when medicinal products prepared from human blood or plasma are administered, the possibility of transmitting infective agents cannot be totally excluded.
Danish: På trods af dette kan muligheden for overførsel af infektiøse stoffer ikke udelukkes totalt, når der administreres lægemidler fremstillet af humant blod eller plasma.
English: Powder and solvent for solution for infusion.
Danish: Pulver og solvens til infusionsvæske, opløsning.
English: Some side effects may be serious: Uncommonly (may affect up to 1 in 100 people), allergic reactions have been observed.
Danish: Der er blevet observeret allergiske reaktioner med hyppigheden ”ikke almindelig” (kan forekomme hos op til 1 ud af 100 mennesker).
English: Respreeza 5,000 mg powder and solvent for solution for infusion One vial contains approximately 5,000 mg of human alpha1-proteinase inhibitor*, as determined by its capacity to neutralize human neutrophil elastase.
Danish: Respreeza 5.000 mg pulver og solvens til infusionsvæske, opløsning Et hætteglas indeholder ca. 5.000 mg human alfa1-proteinasehæmmer* bestemt ud fra dets kapacitet til at neutralisere human neutrofil elastase.
English: What Respreeza is and what it is used for 2.
Danish: Virkning og anvendelse 2.
English: Respreeza 4,000 mg powder and solvent for solution for infusion One vial contains approximately 4,000 mg of human alpha1-proteinase inhibitor*, as determined by its capacity to neutralize human neutrophil elastase.
Danish: Respreeza 4.000 mg pulver og solvens til infusionsvæske, opløsning Et hætteglas indeholder ca. 4.000 mg human alfa1-proteinasehæmmer* bestemt ud fra dets kapacitet til at neutralisere human neutrofil elastase.
English: Solvent: Water for injections
Danish: Opløsningsmiddel: Vand til injektionsvæsker
English: Respreeza 1,000 mg powder and solvent for solution for infusion One vial contains approximately 1,000 mg of human alpha1-proteinase inhibitor*, as determined by its capacity to neutralize human neutrophil elastase.
Danish: Respreeza 1.000 mg pulver og solvens til infusionsvæske, opløsning Et hætteglas indeholder ca. 1.000 mg human alfa1-proteinasehæmmer* bestemt ud fra dets kapacitet til at neutralisere human neutrofil elastase.
English: • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 (see also section 4.4).
Danish: • Overfølsomhed over for det aktive stof eller over for et eller flere af hjælpestofferne anført i pkt.
English: Human alpha1-proteinase inhibitor 5,000 mg
Danish: Human alfa1-proteinasehæmmer 5.000 mg
English: Respreeza 1,000 mg powder and solvent for solution for infusion 3 years
Danish: Respreeza 1.000 mg pulver og solvens til infusionsvæske, opløsning 3 år
English: The infusion solution is normally given over about 15 minutes (about 0.08 ml of solution per kg body weight each min).
Danish: (ca. 0,08 ml infusionsvæske pr. kg kropsvægt i minuttet).
English: Respreeza 4,000 mg powder and solvent for solution for infusion Respreeza 4,000 mg of powder in a glass vial (type I), closed with a rubber (bromobutyl or chlorobutyl) stopper and an aluminium seal with a plastic flip off cap.
Danish: Respreeza 4.000 mg pulver og solvens til infusionsvæske, opløsning Respreeza 4.000 mg pulver i et hætteglas af glas (type I), lukket med en gummiprop (brombutyl eller chlorbutyl) og aluminiumsforsegling med en flip-off hætte af plastik.
English: Respreeza 5,000 mg powder and solvent for solution for infusion 2 years
Danish: Respreeza 5.000 mg pulver og solvens til infusionsvæske, opløsning 2 år
English: Respreeza 5,000 mg powder and solvent for solution for infusion Respreeza 5,000 mg of powder in a glass vial (type I), closed with a rubber (bromobutyl or chlorobutyl) stopper and an aluminium seal with a plastic flip off cap.
Danish: Respreeza 5.000 mg pulver og solvens til infusionsvæske, opløsning Respreeza 5.000 mg pulver i et hætteglas af glas (type I), lukket med en gummiprop (brombutyl eller chlorbutyl) og aluminiumsforsegling med en flip-off hætte af plastik.
English: Respreeza 1,000 mg powder and solvent for solution for infusion Respreeza 1,000 mg of powder in a glass vial (type I), closed with a rubber (bromobutyl or chlorobutyl) stopper and an aluminium seal with a plastic flip off cap.
Danish: Respreeza 1.000 mg pulver og solvens til infusionsvæske, opløsning Respreeza 1.000 mg pulver i et hætteglas af glas (type I), lukket med en gummiprop (brombutyl eller chlorbutyl) og aluminiumsforsegling med en flip-off hætte af plastik.
English: Human alpha1-proteinase inhibitor 4,000 mg
Danish: Human alfa1-proteinasehæmmer 4.000 mg
English: Respreeza 4,000 mg powder and solvent for solution for infusion 2 years
Danish: Respreeza 4.000 mg pulver og solvens til infusionsvæske, opløsning 2 år
English: What Respreeza looks like and contents of the pack
Danish: Udseende og pakningsstørrelser
English: 95 ml of water for injections in a glass vial (type I), closed with a rubber (chlorobutyl) stopper and an aluminium seal with a plastic flip off cap.
Danish: 95 ml vand til injektionsvæsker i hætteglas af glas (type I), lukket med en gummiprop (chlorbutyl) og aluminiumsforsegling med en flip-off hætte af plastik.
English: 76 ml of water for injections in a glass vial (type I), closed with a rubber (chlorobutyl) stopper and an aluminium seal with a plastic flip off cap.
Danish: 76 ml vand til injektionsvæsker i hætteglas af glas (type I), lukket med en gummiprop (chlorbutyl) og aluminiumsforsegling med en flip-off hætte af plastik.
English: Do not freeze the reconstituted solution.
Danish: Rekonstitueret infusionsvæske må ikke nedfryses.
English: After reconstitution with 76 ml solvent, the solution contains approximately 50 mg/ml of human alpha1-proteinase inhibitor.
Danish: Efter rekonstitution med 76 ml solvens indeholder infusionsvæsken ca. 50 mg/ml human alpha1proteinasehæmmer.
English: After reconstitution with 95 ml solvent, the solution contains approximately 50 mg/ml of human alpha1-proteinase inhibitor.
Danish: Efter rekonstitution med 95 ml solvens indeholder infusionsvæsken ca. 50 mg/ml human alpha1proteinasehæmmer.
English: The powder must be reconstituted with water for injections (see instructions on reconstitution in section°6.6) and administered using an intravenous administration set (not supplied).
Danish: Pulveret skal rekonstitueres med vand til injektionsvæsker (se anvisninger om rekonstitution i pkt.
English: The recommended dose of 60 mg / kg bw will take approximately 15 minutes to infuse.
Danish: Det vil tage ca. 15 minutter at infundere den anbefalede dosis på 60 mg/kg kropsvægt.
English: Human alpha1-proteinase inhibitor 1,000 mg
Danish: Human alfa1-proteinasehæmmer 1.000 mg
English: Consequences of an overdose are unknown.
Danish: Hvis du har taget for meget Respreeza Konsekvenserne ved en overdosering er ukendte.
English: •how to prepare and givethis medicine (see the illustrated instructions at the end of this leaflet in
Danish: •hvordan du klargørog giver dette lægemiddel (se de illustrerede anvisninger sidst i denne indlægsseddel i "Information til sundhedspersonale og til patienter, der er egnede til hjemmebehandling/selvbehandling")
English: 20 ml of water for injections in a glass vial (type I), closed with a rubber (chlorobutyl) stopper and an aluminium seal with a plastic flip off cap.
Danish: 20 ml vand til injektionsvæsker i hætteglas af glas (type I), lukket med en gummiprop (chlorbutyl) og aluminiumsforsegling med en flip-off hætte af plastik.
English: After reconstitution with 20 ml solvent, the solution contains approximately 50 mg/ml of human alpha1-proteinase inhibitor.
Danish: Efter rekonstitution med 20 ml solvens indeholder infusionsvæsken ca. 50 mg/ml human alpha1proteinasehæmmer.
English: This medicine contains 1.9mg sodium perml of reconstituted solution.
Danish: Respreeza indeholder 1,9mg natriumpr.
English: Reporting of side effects If you get any side effects, talk to your doctor or healthcare professional.
Danish: - Kontakt lægen eller sundhedspersonalet, hvis en bivirkning bliver værre, eller du får bivirkninger,
English: 1 solvent vial of 95 ml water for injections 1 transfer set 20/20 (Mix2Vial set) for reconstitution
Danish: 1 hætteglas med pulver til engangsbrug 1 hætteglas med 95 ml vand til injektionsvæsker 1 overføringssæt 20/20 (Mix2Vial-sæt) til rekonstitution
English: Respreeza 5,000 mg powder and solvent for solution for infusion:
Danish: Respreeza 5.000 mg pulver og solvens til infusionsvæske, opløsning:
English: Respreeza 5,000 mg powder and solvent for solution for infusion.
Danish: Respreeza 5.000 mg pulver og solvens til infusionsvæske, opløsning.
English: 1 solvent vial of 76 ml water for injections 1 transfer set 20/20 (Mix2Vial set) for reconstitution
Danish: 1 hætteglas med pulver til engangsbrug 1 hætteglas med 76 ml vand til injektionsvæsker 1 overføringssæt 20/20 (Mix2Vial-sæt) til rekonstitution
English: POWDER VIAL
Danish: Åbn Mix2Vial
English: Hypoaesthesia
Danish: Hypæstesi
English: Respreeza 1,000 mg powder and solvent for solution for infusion:
Danish: Respreeza 1.000 mg pulver og solvens til infusionsvæske, opløsning:
English: After reconstitution, the solution should be used immediately.
Danish: Efter fremstilling skal infusionsvæsken anvendes med det samme.
English: Respreeza 4,000 mg powder and solvent for solution for infusion:
Danish: Respreeza 4.000 mg pulver og solvens til infusionsvæske, opløsning:
English: Respreeza 4,000 mg powder and solvent for solution for infusion.
Danish: Respreeza 4.000 mg pulver og solvens til infusionsvæske, opløsning.
English: 1 solvent vial of 20 ml water for injections 1 transfer set 20/20 (Mix2Vial set) for reconstitution
Danish: 1 hætteglas med pulver til engangsbrug 1 hætteglas med 20 ml vand til injektionsvæsker 1 overføringssæt 20/20 (Mix2Vial-sæt) til rekonstitution
English: How to use Respreeza
Danish: Sådan skal du tage Respreeza
English: Respreeza 1,000 mg powder and solvent for solution for infusion.
Danish: Respreeza 1.000 mg pulver og solvens til infusionsvæske, opløsning.
English: Respreeza 5,000 mg powder and solvent for solution for infusion Human alpha1-proteinase inhibitor
Danish: Respreeza 5.000 mg pulver og solvens til infusionsvæske, opløsning Human alfa1-proteinasehæmmer
English: Respreeza 1,000 mg powder for solution for infusion Human alpha1-proteinase inhibitor
Danish: Respreeza 1.000 mg pulver til infusionsvæske, opløsning Human alfa1-proteinasehæmmer
English: Respreeza 1,000 mg powder and solvent for solution for infusion Human alpha1-proteinase inhibitor
Danish: Respreeza 1.000 mg pulver og solvens til infusionsvæske, opløsning Human alfa1-proteinasehæmmer
English: Respreeza 4,000 mg powder and solvent for solution for infusion Human alpha1-proteinase inhibitor
Danish: Respreeza 4.000 mg pulver og solvens til infusionsvæske, opløsning Human alfa1-proteinasehæmmer
English: Dose
Danish: Øjne
English: Respreeza 5,000 mg powder for solution for infusion Human alpha1-proteinase inhibitor
Danish: Respreeza 5.000 mg pulver til infusionsvæske, opløsning Human alfa1-proteinasehæmmer
English: Respreeza 4,000 mg powder for solution for infusion Human alpha1-proteinase inhibitor
Danish: Respreeza 4.000 mg pulver til infusionsvæske, opløsning Human alfa1-proteinasehæmmer
English: - If you have any further questions, ask your doctor or healthcare professional.
Danish: - Spørg lægen eller sundhedspersonalet, hvis der er mere, du vil vide.
English: Nausea
Danish: Rygevaner
English: Lymph node pain
Danish: Smerter i lymfeknuder
English: This summary was last updated in July 2010.
Danish: Dette sammendrag blev sidst ajourført i juli 2010.
English: Pigs and horses should not be slaughtered for 5 days.
Danish: Svin og heste må ikke slagtes i 5 dage.
English: What is the time to allow before the animal can be slaughtered and the meat used for human consumption (withdrawal period)?
Danish: Hvor lang tid skal der gå, før dyret kan slagtes, og kødet kan anvendes til konsum (tilbageholdelsestid)?
English: After the last administration of Meloxidyl cattle should not be slaughtered for 15 days and the milk not used for 5 days.
Danish: Efter den sidste indgivelse af Meloxidyl må kvæget ikke slagtes i 15 dage, og mælken må ikke anvendes i 5 dage.
English: Accidental self-injection may cause pain.
Danish: Utilsigtet selvinjektion kan forårsage smerter.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Meloxidyl to Ceva Santé Animal on 15 January 2007.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Meloxidyl til Ceva Santé Animal den 15. januar 2007.
English: EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) MELOXIDYL EPAR summary for the public
Danish: EUROPÆISK OFFENTLIG VURDERINGSRAPPORT (EPAR) MELOXIDYL EPAR - sammendrag for offentligheden
English: They usually occur during the first week of treatment and tend to be temporary.
Danish: Bivirkningerne opstår som regel inden for den første uge af behandlingen og er generelt forbigående.
English: People who are hypersensitive to NSAIDs should avoid contact with Meloxidyl.
Danish: Personer, som er overfølsomme over for NSAID'er, skal undgå kontakt med Meloxidyl.
English: A temporary swelling at the injection site can occur but resolves without intervention.
Danish: Der kan opstå en midlertidig hævelse ved injektionsstedet, som dog forvinder uden behov for indgreb.
English: Other information about Meloxidyl:
Danish: Andre oplysninger om Meloxidyl:
English: They include loss of appetite, vomiting, diarrhoea, blood in the stools and apathy (lack of vitality).
Danish: Disse omfatter appetitløshed, opkastning, diarré, blod i afføringen og apati (mangel på vitalitet).
English: In horses, anaphlylactoid (hypersensitivity) reactions can occur and should be treated symptomatically.
Danish: Hos heste kan der opstå anafylaktiske reaktioner (overfølsomhed), som skal behandles symptomatisk.
English: It can be used for both acute (sudden) disorders, such as those seen after an injury, and chronic (long-term) disorders.
Danish: Det kan anvendes både ved akutte (pludselige) sygdomme, f.eks. efter en skade, og ved kronisk (langvarig) sygdom.
English: The Committee recommended that Meloxidyl should be given a marketing authorisation.
Danish: Udvalget anbefalede udstedelse af markedsføringstilladelse for Meloxidyl.
English: Meloxidyl is a medicinal product that contains the active substance meloxicam.
Danish: Meloxidyl er et lægemiddel, der indeholder det aktive stof meloxicam.
English: If someone swallows the medicinal product, the advice of a doctor should be sought immediately.
Danish: Hvis en person utilsigtet indtager lægemidlet, skal der straks søges lægehjælp.
English: Meloxidyl is a pale green oral suspension (1.5 mg/ml) for dogs and (0.5 mg/ml) for cats, which is mixed into the food, and a yellow solution for injection (5 mg/ml) for dogs and cats as well as solution for injection (20 mg/ml) for cattle, pigs and horses.
Danish: Meloxidyl er en lysegrøn oral suspension (1,5 mg/ml) til hunde og (0,5 mg/ml) til katte, som blandes i foderet, og en gul injektionsvæske, opløsning, (5 mg/ml) til hunde og katte samt en injektionsvæske, opløsning, (20 mg/ml) til kvæg, svin og heste.
English: A study looked at how Meloxidyl was absorbed and its effects in the body, in comparison with Metacam.
Danish: I en undersøgelse så man nærmere på, hvordan Meloxidyl blev optaget i kroppen og på dets virkninger i kroppen i forhold til Metacam.
English: Meloxidyl contains meloxicam, which belongs to a class of medicines called non-steroidal anti-inflammatory drugs (NSAIDs).
Danish: Meloxidyl indeholder meloxicam, som tilhører en lægemiddelgruppe, der kaldes ikke-steroide antiinflammatoriske lægemidler (NSAID'er).
English: The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that, in accordance with EU requirements, Meloxidyl has been shown to be bioequivalent to Metacam.
Danish: Udvalget for Veterinærlægemidler (CVMP) konkluderede, at det i overensstemmelse med EU-kravene er blevet påvist, at Meloxidyl er bioækvivalent med Metacam.
English: Meloxidyl is a ‘generic': this means that Meloxidyl is similar to a ‘reference veterinary medicinal product' already authorised in the EU (Metacam).
Danish: Meloxidyl er et ”generisk lægemiddel”, hvilket betyder, at Meloxidyl ligner et ”referenceveterinærlægemiddel”, som allerede er godkendt i EU (Metacam).
English: In cattle and pigs, subcutaneous, intramuscular as well as intravenous administration is well tolerated; only a slight temporary swelling at the injection site following subcutaneous administration was observed in less than 10% of the cattle treated in clinical studies.
Danish: Hos kvæg og svin er subkutan, intramuskulær og intravenøs indgivelse veltolereret, og efter subkutan injektion blev der kun observeret en lille midlertidig hævelse ved injektionsstedet hos mindre end 10 % af det kvæg, der blev behandlet i de kliniske undersøgelser.